Clinical trial
Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease
NCT06355310 is registered in ClinicalTrials.gov with Justin Ryder as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease
- Lead sponsor
- Justin Ryder
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- April 10, 2025
- Completion date
- February 1, 2028
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.